SCHEMBL1365809

SCHEMBL1365809

O=C(CC(=O)c1cc2cc(Br)ccc2oc1=O)c1cc2cc(Br)ccc2oc1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.72
GRIN2A Q12879 1/20 0.72
GRIN2B Q13224 1/20 0.72
GRIN2C Q14957 1/20 0.72
GPR35 Q9HC97 1/20 0.72
MAOA P21397 1/20 0.70
CA12 O43570 2/20 0.64
CA9 Q16790 2/20 0.64
ALDH1A1 P00352 5/20 0.64
USP2 O75604 2/20 0.64
HTT P42858 2/20 0.64
F12 P00748 1/20 0.63
KMT2A Q03164 4/20 0.61
MAPT P10636 2/20 0.61
ALDH2 P05091 1/20 0.61
ALDH1A3 P47895 1/20 0.61
HPGD P15428 2/20 0.61
ALOX12 P18054 1/20 0.61
KDM4E B2RXH2 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3065914 0.85 TSHR (0.71) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL1367996 0.85 GRIN1 (0.79) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL1367953 0.85 GRIN1 (0.79) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL569881 0.84 GPR35 (1.00) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL3273927 0.83 GRIN1 (0.74) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL980429 0.83 MAOA (1.00) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL1808756 0.82 MAOA (0.71) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL1368479 0.81 TSHR (0.51) GRIN1GRIN2AGRIN2BGRIN2CGPR35
SCHEMBL1367592 0.81 TSHR (0.74) GPR35CA12CA9ALDH1A1F12
SCHEMBL11484256 0.79 MAOB (0.74) GRIN1GRIN2AGRIN2BGRIN2CGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS GRIN1 4625/4885GRIN2A 4789/4885GRIN2B 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.